- ►annals.org [PDF] RM Gulick, JW Mellors, D Havlir, JJ Eron, A … - Annals of internal …, 2000 - Am Coll Physicians Roy M. Gulick, MD, MPH; John W. Mellors, MD; Diane Havlir, MD; Joseph J. Eron, MD; Anne
Meibohm, PhD; Jon H. Condra, PhD; Fred T. Valentine, MD; Deborah McMahon, MD; Charles
Gonzalez, MD; Leslie Jonas, BS; Emilio A. Emini, PhD; Jeffrey A. Chodakewitz, MD; ... Cited by 157 - Related articles - BL Direct - All 4 versions
OJ Cohen, AS Fauci - New England Journal of Medicine, 1998 - content.nejm.org The addition of human immunodeficiency virus type 1 (HIV-1)–protease inhibitors to the armamentarium
of antiretroviral drugs has dramatically improved the prognosis for HIV-infected persons. 1 , 2
, 3 Although these agents do not eradicate the virus, 4 , 5 , 6 they can provide long-term ... Cited by 47 - Related articles - BL Direct - All 5 versions
GR Kaufmann, DA Cooper - Current opinion in microbiology, 2000 - Elsevier For a decade, therapeutic options against HIV-1 infection were limited, consisting only of a single
class of drugs, the nucleoside analogue reverse transcriptase inhibitors (nRTIs). The impact
of these agents on plasma HIV-1 RNA levels was modest and the development of serious ... Cited by 35 - Related articles - BL Direct - All 6 versions
RM Gulick, A Meibohm, D Havlir, JJ Eron, A Mosley, JA … - Aids, 2003 - journals.lww.com Page 1. CONCISE COMMUNICATION Six-year follow-up of HIV-1-infected adults in
a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine Roy
M. Gulicka, Anne Meibohmb, Diane Havlirc, Joseph J. Erond, ... Cited by 49 - Related articles - BL Direct - All 3 versions
G Dornadula, G Nunnari, M Vanella, J Roman … - The Journal of …, 2001 - UChicago Press Featured in US News & World Report "Common Cold Virus Alters Body's Genes" October
24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus
(RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given ... Cited by 33 - Related articles - BL Direct - All 5 versions
F García, MM Alonso, J Romeu, H Knobel, J … - JAIDS Journal of …, 2000 - journals.lww.com *Infectious Diseases Unit and Microbiology and Immunology Laboratories, Institut d'Investigacions
Biome`diques August Pi I Sunyer, Hospital Clınic, Faculty of Medicine, University of
Barcelona, Barcelona; †Infectious Diseases Unit, Hospital Universitario de Canarias, ... Cited by 22 - Related articles - BL Direct - All 3 versions
RJ Pomerantz - Biomedicine & pharmacotherapy= Biomédecine & …, 2000 - ncbi.nlm.nih.gov 1: Biomed Pharmacother. 2000 Feb;54(1):13-5. Residual HIV-1 replication. Pomerantz RJ.
Dorrance H. Hamilton Laboratories, Department of Medicine, Jefferson Medical College,
Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. ... Cited by 2 - Related articles - All 3 versions
DM Coen - Trends in Microbiology, 1998 - Elsevier Several of the most important developments in the management and understanding of HIV over
the past few years derive from the use of new, potent antiviral drugs. Not only have these drugs
prolonged and improved the lives of patients infected with HIV, but studies using these ... Related articles - BL Direct - All 3 versions
